Who is sponsoring NCT04001465?

NCT04001465 is sponsored by University of Saskatchewan.

What drugs are being tested in NCT04001465?

Interventions in NCT04001465: Volumetric methacholine challenge unmodified, Modified volumetric methacholine challenge.

What condition does NCT04001465 study?

NCT04001465 studies Airway Hyper Responsiveness.

Is NCT04001465 still recruiting?

NCT04001465 is currently completed. Last updated 27 March 2020.

Last reviewed 2020-03-27 · How we verify

NCT04001465

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Determining Baseline Respiratory Duty Cycles in Subjects With and Without Airway Hyperresponsiveness

Completed NA Last updated 27 March 2020

What this trial tests

NA trial testing Volumetric methacholine challenge unmodified in Airway Hyper Responsiveness in 34 participants. Completed in 30 June 2019.

Timeline

14 May 2019

Primary endpoint
30 June 2019

30 June 2019

Quick facts

Lead sponsor	University of Saskatchewan
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	34
Start date	14 May 2019
Primary completion	30 June 2019
Estimated completion	30 June 2019
Sites	1 location across Canada

Drugs / interventions tested

Volumetric methacholine challenge unmodified
Modified volumetric methacholine challenge

Conditions studied

Airway Hyper Responsiveness — all drugs for Airway Hyper Responsiveness →

Sponsor

University of Saskatchewan

Who can join

18 and older, any sex, with Airway Hyper Responsiveness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study investigates the inspiratory duty cycle in subjects with and without airway hyper-responsiveness both at rest and during a bronchoprovocation challenge. The primary goal is to determine an average inspiratory duty cycle for standard use in the calculation of bronchoprovocation test results.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Saskatchewan trials

Trials by the same sponsor.

NCT07433686 — Saskatoon Berry Juice for Muscle Recovery · NA · not yet recruiting
NCT07489469 — Effectiveness of an AI Scribe Compared to Routine Templates for Clinical Documentation in Orthopedic Consultations · NA · completed
NCT06946316 — Dairy vs Plant-based Beverages for Improving Bone Health During Exercise · NA · recruiting
NCT04276857 — Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer · NA · recruiting
NCT03401294 — Conversion From Unresectable To Resectable Metastatic Colorectal Cancer. · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04001465 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Saskatchewan
Last refreshed: 27 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04001465.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing